Exploring the therapeutic potential of interleukin-6 receptor blockade in autoimmune diseases using drug target mendelian randomization

Authors:

Abstract
The blockade of the interleukin 6 receptor (IL-6R) demonstrates significant potential in various autoimmune diseases (ADs); however, the underlying therape
Funding Information
  • National Natural Science Foundation of China (81601139)
  • Natural Science Foundation of Hunan Province (2024JJ5576)

This publication has 50 references indexed in Scilit: